Evidence map›Paper›PMID 40655903›Full record

ReviewEpilepsy currents2025

Epilepsy Surgery in the Last 10 Years: Advancements and Controversies.

Jorge A Gonzalez-Martinez

Abstract readReview
In one paragraph

Review in Epilepsy currents, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jorge A Gonzalez-MartinezUniversity of Pittsburgh, USA.ORCID https://orcid.org/0000-0002-9936-7034

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The past decade has witnessed a transformative evolution in epilepsy surgery, marked by the introduction and maturation of the so-called "minimally invasive interventions," neuromodulation strategies, and personalized surgical approaches. These developments have redefined treatment paradigms for drug-resistant epilepsy, offering safer, more targeted, and sometimes more effective alternatives to traditional open resections. The 2025 AES Surgery Symposium served as a platform for synthesizing the state-of-the-art in this dynamic field, highlighting not only the significant strides made in surgical and neurotechnological innovation but also the unresolved controversies that continue to shape clinical practice. This review aims to distill key themes from the symposium, including emerging surgical techniques, the resurgence of stereo-electroencephalography (SEEG)-guided thermocoagulation, the further integration of neuromodulation into mainstream epilepsy care, and the future of individualized surgical planning through advanced imaging and connectomics. While these innovations hold remarkable promise, their efficacy, accessibility, and long-term impact require rigorous scrutiny and global discourse.

Indexed as

epilepsy surgeryhemispherectomylaser interstitial therapyneuromodulationradiofrequency thermocoagulation

Identifiers

PMID40655903
PMCPMC12240976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.